<DOC>
	<DOCNO>NCT02036307</DOCNO>
	<brief_summary>This trial two market fish oil supplement , one high EPA : DHA ratio high DHA : EPA ratio , examine differential effect platelet function , blood pressure , fast triglyceride level .</brief_summary>
	<brief_title>Supplementation With Omega-3 : Mechanism Action</brief_title>
	<detailed_description>Observational study show fish consumption associate low risk cardiovascular disease , clinical trial demonstrate fish oil nutritional supplementation associate improvement cardiometabolic risk factor profile include fast triglyceride blood pressure . However , mechanisms action fish oil well understood . Specifically , effect different composition term ratio fatty acid EPA DHA know . We propose pilot feasibility study fish oil nutritional supplementation 40 healthy adult participant two different commercially available fish oil ( high EPA/DHA ratio , high DHA/EPA ratio , sample 20 per group ) hypothesis 4 week supplementation fish oil result differential change platelet function , blood pressure fast triglyceride level . We also bank blood urine future mechanistic study . This pilot study allow u collect preliminary data definitive mechanistic study effect fish oil supplementation demonstrate feasibility protocol .</detailed_description>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>Healthy adult 2075 year age . Participant Principal Investigator 's prior study study agree contacted future study . Current user fish oil supplement Current user statin Allergy fish seafood product Diagnosed/treated diabetes mellitus Using aspirin NSAIDS `` bloodthinning medication ''</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Fish oil</keyword>
	<keyword>Triglycerides</keyword>
	<keyword>Blood pressure</keyword>
</DOC>